摘要
^(177)Lu标记的前列腺特异性膜抗原(prostate specific membrane antigen,PSMA)放射性配体疗法已在国外获批应用于晚期前列腺癌治疗,且正在国内开展多项临床试验。专家组参考国外经验和观点,并结合国内临床实践和实测数据,形成^(177)Lu-PSMA放射性配体疗法在前列腺癌临床应用中的专家共识。
^(177)Lu-prostate specific membrane antigen(PSMA)radio-ligand therapy has been approved abroad for advanced prostate cancer and has been in several clinical trials in China.Based on domestic clinical practice and experimental data and referred to international experience and viewpoints,the expert group forms a consensus on the clinical application of^(177)Lu-PSMA radioligand therapy in prostate cancer to guide clinical practice.
作者
刘国兵
卓维海
顾宇参
杨志
陈跃
樊卫
郭剑明
谭建
朱小华
霍力
兰晓莉
李彪
缪蔚冰
宋少莉
徐浩
田蓉
罗全勇
王峰
王雪梅
杨爱民
戴东
邓智勇
赵晋华
陈晓良
范岩
高再荣
韩星敏
蒋宁一
匡安仁
林岩松
刘甫庚
楼岑
苏新辉
唐立钧
王辉
王欣璐
杨福洲
杨辉
赵新明
杨波
黄晓冬
陈继亮
李思进
汪静
李亚明
石洪成
LIU Guobing;ZHUO Weihai;GU Yushen;YANG Zhi;CHEN Yue;FAN Wei;GUO Jianming;TAN Jian;ZHU Xiaohua;HUO Li;LAN Xiaoli;LI Biao;MIAO Weibing;SONG Shaoli;XU Hao;TIAN Rong;LUO Quanyong;WANG Feng;WANG Xuemei;YANG Aimin;DAI Dong;DENG Zhiyong;ZHAO Jinhua;CHEN Xiaoliang;FAN Yan;GAO Zairong;HAN Xingmin;JIANG Ningyi;KUANG Anren;LIN Yansong;LIU Fugeng;LOU Cen;SU Xinhui;TANG Lijun;WANG Hui;WANG Xinlu;YANG Fuzhou;YANG Hui;ZHAO Xinming;YANG Bo;HUANG Xiaodong;CHEN Jiliang;LI Sijin;WANG Jing;LI Yaming;SHI Hongcheng(Zhongshan Hospital,Fudan University;Shanghai Institute of Medical Imaging,Institute of Nuclear Medicine,Fudan University,Cancer Prevention and Treatment Center,Zhongshan Hospital;Institute of Radiation Medicine,Fudan University;Beijing Cancer Hospital;The Affiliated Hospital of Southwest Medical University;Sun Yat-sen University Cancer Center;Tianjin Medical University General Hospital;Tongji Hospital,Tongji Medical College of Huazhong University of Science and Technology;Peking Union Medical College Hospital;Union Hospital,Tongji Medical College of Huazhong University of Science and Technology;Ruijin Hospital,Shanghai Jiao Tong University School of Medicine;The First Affiliated Hospital of Fujian Medical University;Fudan University Shanghai Cancer Center;The First Affiliated Hospital of Jinan University;West China Hospital,Sichuan University;Shanghai Sixth People’s Hospital,Shanghai Jiao Tong University School of Medicine;Nanjing First Hospital;The First Affiliated Hospital of University of Science and Technology of China;The First Affiliated Hospital of Xi’an Jiaotong University;Tianjin Cancer Hospital Airport Hospital;Yunnan Cancer Hospital;Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine;Chongqing University Cancer Hospital;Peking University First Hospital;The First Affiliated Hospital of Zhengzhou University;The Seventh Affiliated Hospital,Sun Yat-sen University;Beijing Hospital;Sir Run Run Shaw Hospital,Zhejiang University School of Medicine;The First Affiliated Hospital,Zhejiang University School of Medicine;Jiangsu Province Hospital;Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine;The First Affiliated Hospital of Guangzhou Medical University;Yaan People’s Hospital;Henan Cancer Hospital;The Fourth Hospital of Hebei Medical University;Anning First People’s Hospital,Kunming University of Science and Technology;Shanghai Guohe Science&Technology Development Co.,Ltd.;Division of Radiation Safety Regulation,Shanghai Municipal Bureau of Ecology and Environment;First Hospital of Shanxi Medical University;Xijing Hospital,Air Force Military University;The First Hospital of China Medical University)
出处
《中国临床医学》
2024年第5期844-850,F0003,共8页
Chinese Journal of Clinical Medicine
基金
国家临床重点专科建设项目(YWP2022-007)
上海市2023年度创新医疗器械应用示范项目(23SHS01200)
工业和信息化部2022年国家重点研发计划(CEIEC-2022-ZM02-0219)。